Nano-X Imaging Ltd. Cost of Revenue 2011-2026 | NNOX

Cost of Revenue is a financial metric that reflects all direct costs associated with the production of goods or the provision of services that directly led to revenue during the reporting period. It is the total amount of expenses incurred by the company to deliver its products or services, including both production costs and related expenses necessary for delivery or customer support.

What is included in the cost of revenue

Cost Category	Examples
Production Costs	Materials, wages of production staff, depreciation of equipment
Service and Support	Customer service, user support, technical assistance
Delivery and Logistics	Packaging, delivery of goods to customers
Hosting and Infrastructure	Servers, cloud platforms (especially for IT and SaaS companies)
Content and Licenses	License purchases, production royalties (e.g., in streaming services)

Importance of the Metric

Helps to understand how costly the revenue-generating process is.
A high cost of revenue may indicate:
Poor cost control
Low operational efficiency
A low cost of revenue combined with high revenue indicates high profitability and business competitiveness.

Annual Cost of Revenue Nano-X Imaging Ltd.

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
21.9 M	16.5 M	15.5 M	2.82 M	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
21.9 M	2.82 M	14.2 M

Cost of Revenue of other stocks in the Medical devices industry

Issuer	Cost of Revenue	Price	% 24h	Market Cap	Country
Bruker Corporation BRKR	1.72 B	$ 36.74	-	$ 5.47 K	USA
ClearPoint Neuro CLPT	14.3 M	$ 9.38	-	$ 266 M	USA
Acutus Medical AFIB	10.3 M	-	-26.83 %	$ 2.62 M	USA
Cytosorbents Corporation CTSO	10.6 M	$ 0.59	-	$ 36.7 M	USA
AdaptHealth Corp. AHCO	2.64 B	$ 12.07	-	$ 1.63 B	USA
Allied Healthcare Products AHPI	24.5 M	-	3.58 %	$ 2.21 M	USA
Delcath Systems DCTH	11.8 M	$ 9.7	-	$ 347 M	USA
EDAP TMS S.A. EDAP	36 M	$ 3.45	1.77 %	$ 129 M	France
Edwards Lifesciences Corporation EW	1.33 B	$ 81.19	-	$ 47.5 B	USA
Globus Medical GMED	958 M	$ 88.6	-	$ 12 B	USA
Apollo Endosurgery APEN	34.4 M	-	-	$ 475 M	USA
Helius Medical Technologies HSDT	583 K	$ 1.9	-	$ 1.15 M	USA
Integra LifeSciences Holdings Corporation IART	728 M	$ 9.31	-	$ 717 M	USA
Inspire Medical Systems INSP	133 M	$ 54.14	-	$ 1.59 B	USA
IRIDEX Corporation IRIX	33.4 M	$ 1.0	-	$ 16.9 M	USA
Integer Holdings Corporation ITGR	1.35 B	$ 85.63	-	$ 2.97 B	USA
OrthoPediatrics Corp. KIDS	63.7 M	$ 15.94	-	$ 374 M	USA
LENSAR LNSR	31.3 M	$ 5.89	-2.81 %	$ 70.4 M	USA
Avinger AVGR	5.65 M	-	-20.74 %	$ 369 K	USA
Medtronic PLC MDT	11.6 B	$ 86.28	-	$ 111 B	USA
Align Technology ALGN	1.2 B	$ 171.87	-	$ 12.9 B	USA
Myomo MYO	14 M	$ 0.7	-	$ 29.3 M	USA
AxoGen AXGN	57.9 M	$ 32.64	-	$ 1.5 B	USA
Axonics Modulation Technologies AXNX	76 M	-	-	$ 3.31 B	USA
Orthofix Medical OFIX	256 M	$ 11.77	-	$ 466 M	Curacao
Aziyo Biologics AZYO	5.7 M	-	1.37 %	$ 20.5 M	USA
Penumbra PEN	461 M	$ 329.87	-	$ 12.8 B	USA
Neovasc NVCN	556 K	-	-	$ 111 M	Canada
Insulet Corporation PODD	768 M	$ 203.5	-	$ 14.3 B	USA
Sintx Technologies SINT	557 K	$ 2.53	0.4 %	$ 7.02 M	USA
Butterfly Network BFLY	33.2 M	$ 4.13	-0.24 %	$ 874 M	USA
Smith & Nephew plc SNN	1.54 B	$ 32.63	-	$ 23.8 B	Britain
Stryker Corporation SYK	9.05 B	$ 332.3	-	$ 127 B	USA
Tactile Systems Technology TCMD	79.4 M	$ 24.57	-	$ 562 M	USA
TELA Bio TELA	25.6 M	$ 0.63	5.47 %	$ 29.6 M	USA
TransMedics Group TMDX	243 M	$ 104.8	-	$ 3.56 B	USA
Tandem Diabetes Care TNDM	469 M	$ 19.17	-	$ 1.3 B	USA
BIOLASE BIOL	32.4 M	-	-13.19 %	$ 166 K	USA
BioSig Technologies BSGM	57 K	-	37.08 %	$ 85.7 M	USA